The
arrival of multiple COVID-19 vaccines in 2021 are expected to
improve public confidence in an economic recovery and revive
deal-making, say bankers. Market stability and continued access
to capital that led to a resurgence in transactions in the
second half of the year is expected to continue.
Over $158.7 billion worth of M&A deals were announced in 2020,
making it the slowest year since 2011, compared with $234
billion in the previous year, data from Refinitiv showed.
David Savard, head of M&A at National Bank Financial, said after
COVID-19 put everything on pause, the focus shifted to
restructuring transactions.
"There were a few others that were in the pipeline that ended up
going through a bit of a difficult period with some
renegotiations due to COVID," Savard added.
Of the deals announced in 2020, almost $80 billion came in the
fourth quarter, the most active fourth quarter in at least five
years, according to the data.
CIBC World Markets Inc, Goldman Sachs & Co and RBC Capital
Markets took the top three spots in the advisory rankings.
Financials-focused deals led the recovery in 2020, with Intact
Financial's joint agreement to buy British insurance group RSA.
"You've certainly seen the asset management sector much more
active in the second half of last year and that should continue
into this year," said David Rawlings, chief executive officer
for Canada at JPMorgan Chase & Co.
Emmanuel Pressman, partner at Osler, Hoskin & Harcourt LLP, said
businesses are prepared to "reset the M&A button" and
re-evaluate growth strategy.
"We've seen this glut of M&A activity in the fourth quarter as a
result of this reset," Pressman said, adding there is also a
meaningful pipeline of activity across a range of sectors.
($1 = 0.7343 pounds)
(Reporting by Maiya Keidan; Editing by Lisa Shumaker)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|